T2	Participants 14 93	irresectable hepatocellular carcinoma with repeated transient dearterialization
T1	Participants 179 400	40 patients with the irresectable hepatocellular carcinoma (HCC) admitted to the department of HPB surgery in the First Affiliated Hospital of SUMS were randomized into two groups: (20 each) from Feb. 1994 to April, 1995.
